Results 141 to 150 of about 169,224 (213)

Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoring. [PDF]

Neurooncol Adv
Riviere-Cazaux C, Suzuki Y, Kizilbash Z, Laxen WJ, Lacey JM, Wipplinger TM, Warrington AE, Keough MB, Kamga LF, Andersen KM, Canaday N, Kosel ML, Tortorelli S, Sener U, Ruff MW, Decker PA, Eckel-Passow JE, Kizilbash SH, Kaufmann TJ, Burns TC.   +19 more
europepmc   +1 more source

M2 macrophage infiltration associated with CXCL8 predicts grade 4 prognosis and differentiates glioma grades. [PDF]

Discov Oncol
Liu WH, Lee CC, Chang YJ, Lee AW, Huang CY, Vo TNA, Wu YF, Lin JC.   +7 more
europepmc   +1 more source

Grading of glioma and prediction of IDH mutation status via longitudinal relaxation time in rotating frame mapping on 5-T magnetic resonance imaging: added value to amide proton transfer-weighted imaging. [PDF]

Quant Imaging Med Surg
Dong L, Chen H, Dai G, Chen X, Yin D, Song X, Liu Y, Qian Y.   +7 more
europepmc   +1 more source

Thalamic gliomas: A systematic review and meta-analysis. [PDF]

Surg Neurol Int
Al-Shalchy AK, Al-Taie RH, Ali Al-Khafaji NH, Saad MAB, Al-Khazaali YM, Shahadha AA, Algabri MH, Hazim MA, Ismail M.   +8 more
europepmc   +1 more source

The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activation. [PDF]

Transl Cancer Res
Ji D, Li J, Wang P, Gao S, Li W.
europepmc   +1 more source

Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances. [PDF]

Front Pharmacol
Han M, Zhou Z, Qian B, Zhang Y, Peng C, Peng F.   +5 more
europepmc   +1 more source

Seizure Presentation of a Grade II Astrocytoma in a Patient With Ollier's Disease: A Case Report and Brief Review. [PDF]

Cureus
Vail M, Slosser H, Steele R, Curtis B, Henry D.   +4 more
europepmc   +1 more source

SERPINA3 facilitates malignant progression and remodels tumor immune microenvironment in glioma. [PDF]

Biochem Biophys Rep
Wen W, Zhang Q.
europepmc   +1 more source

Metabolic reprogramming and immunosenescence: a new sight for glioma therapy. [PDF]

Front Cell Dev Biol
Fan H, Yang S, Lu Q, Chang L.
europepmc   +1 more source

Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies. [PDF]

Front Immunol
Jabri A, Mhannayeh A, Taftafa B, Alsharif M, Sibai D, Alsharif R, Abbad T, Elsalti A, Ahmed Z, Salma J, Khan MI, Yaqinuddin A.   +11 more
europepmc   +1 more source